iNeuro40+™ Project

iNeuro40+™ Project

40 Project Description

Forty-seven million people have been diagnosed with dementia globally with an estimate of three times increase by 2050. Alzheimer’s Disease (AD) is one the most causative factors to induce dementia. AD is a neurodegenerative disease related to the extensive cellular aggregates of amyloid B plaques and intercellular tangles made of hyperphorylated protein in cortical and limbic areas of the brain. Functional aspects correlates to memory deficits and cognitive dysfunction.

Advent of Acoustical Medicine

Perhaps the use of the stimulations of acoustics from ancient drum beats to current possible the influence of day/night rhythms to depression is an ancient method of regulating body balance represents a new vision in health care. The revelation that external rhythmic sounds impacts the brain frequencies and mood have been scientifically demonstrated (Maxfield, 2001; Institution of Transpersonal Psychology Dissertations) should not be surprising with the obvious reactions to various music arrangements.


Currently there is a global of search for stimulating the immune system through exposure to 40 hertz, which additional interest in biofeedback circles to understand brain states of Delta, Theta, Alpha, Beta and Gamma stimulation. This is certainly a frontier in modern medicine beyond surgery and chemistry alone.


The use of electricity has shown its use through the invention of the Pacemaker for heart rhythms, as well pain management through STENS stimulation. Light stimulation has been used in regulating depressive features. 

Acoustical Medicine

The neuro40+ Modification 

As acoustical physics has come of age, the mathematical formulations can be easily tracked for maximum benefit through regulation of conscious control. Such equations are easily applied through the findings of quantum physics and music composition writings.  

 

A major explanation has been written by Chan et al. (2021) on the topic of Frequencies and their impact on brain function in “Induction of Specific Brain Oscillations” on which  impact the functions of immunity of neural pathways and should be embraced in the study of Alzheimer’s Disease directly.


The Bio-Acoustical Utilization Device (BAUD) was patented by Lawlis and Lawlis and formally exempted the device as a “biofeedback Treatment” by the FDA. Its underlying process was a multiple channel frequency sound that related to brain function. Its method for relaxation stimulation was to pair stress frequencies with relaxation-related frequencies in the Alpha and Theta ranges. Validation studies are listed in the “References”.


With the attention on the 40 Hertz frequency studied specifically for Alzheimer’s Disease, the dominant setting for 40 Hertz was predetermined as the major stimulus with the additional setting of 4 – 12 Hertz above 40 Hertz creating a binaural sound (Theta-Alpha) being set by the participant. Sound volumes are also set by the participant. 


The strategy is to provide a process in which the brain can eradicate the toxicity in the brain through stimulation of the immune function, thus freeing the neurological functioning to function in a normal manner and eliminate the cause of brain disease. 


Ongoing research is being done to better understand the “Forty Hertz plus frequencies” for the broad spectrum of brain pathology. This is a challenging and exciting era in reliable and safe interventions.

©Copyright, All Rights Reserved, BAUD Energetics, Corp., 2013-2024